Cargando…
Clinical establishment of a laboratory developed quantitative HDV PCR assay on the cobas6800 high-throughput system
BACKGROUND & AIMS: Currently available HDV PCR assays are characterized by considerable run-to-run and inter-laboratory variability. Hence, we established a quantitative reverse transcription real-time PCR (RT-qPCR) assay on the open channel of a fully automated PCR platform (cobas6800, Roche) o...
Autores principales: | Pflüger, Lisa Sophie, Nörz, Dominik, Volz, Tassilo, Giersch, Katja, Giese, Annika, Goldmann, Nora, Glebe, Dieter, Bockmann, Jan-Hendrik, Pfefferle, Susanne, Dandri, Maura, Schulze zur Wiesch, Julian, Lütgehetmann, Marc |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8531665/ https://www.ncbi.nlm.nih.gov/pubmed/34712932 http://dx.doi.org/10.1016/j.jhepr.2021.100356 |
Ejemplares similares
-
Both interferon alpha and lambda can reduce all intrahepatic HDV infection markers in HBV/HDV infected humanized mice
por: Giersch, Katja, et al.
Publicado: (2017) -
High rates of cirrhosis and severe clinical events in patients with HBV/HDV co-infection: longitudinal analysis of a German cohort
por: Bockmann, Jan-Hendrik, et al.
Publicado: (2020) -
Strain-specific responsiveness of hepatitis D virus to interferon-alpha treatment
por: Giersch, Katja, et al.
Publicado: (2023) -
In Vivo Models of HDV Infection: Is Humanizing NTCP Enough?
por: Giersch, Katja, et al.
Publicado: (2021) -
Pushing beyond specifications: Evaluation of linearity and clinical performance of the cobas 6800/8800 SARS-CoV-2 RT-PCR assay for reliable quantification in blood and other materials outside recommendations
por: Nörz, Dominik, et al.
Publicado: (2020)